Integrating Medications for Alcohol Use Disorder into Palliative Care

Integrating Medications for Alcohol Use Disorder into Palliative Care

Host: National Council for Mental Wellbeing
Recorded: April 8, 2025
Enduring Training

Overview

This webinar explores integrating AUD treatment into palliative care and solutions to improve access to and experiences of palliative care and MAUD. Learners will hear from a pharmacology and palliative care expert about MAUD, palliative care and the benefits of combining the two.

Providing palliative care to individuals with a history of alcohol use or alcohol use disorder (AUD) requires understanding the various characteristics, comorbidities, impacts and treatments for AUD, including medications for AUD (MAUD).

Up to 28% of inpatient palliative care patients have experienced challenges with alcohol use, and a large percentage of them (67% to 87%) are first identified as having a history of alcohol dependence when they enter into the palliative care setting. Because of associated and comorbid conditions, and the perceived risks associated with them, medications for AUD (MAUD) often remain underused within palliative care settings. Improving access to person-centered palliative care for people with AUD would allow clinicians to consider these factors as a part of a holistic, multidisciplinary, person-centered care approach to treating AUD and other associated and comorbid conditions.

This course is eligible for 1 NBCC Contact Hour and 1 NAADAC CE. 

The target audience for this intermediate level activity includes: All types of healthcare professionals. 

The ACGME Competencies include: Patient Care and Procedural Skills and Medical Knowledge.

Learning Objectives

Upon completion, learners will be able to:

1. Review how palliative care fits into the management of patients with AUD.
2. Determine therapeutic considerations when selecting MAUD for palliative care patients.
3. Identify three ways in which palliative care can support patients with AUD.

Open Registration: 04/08/2025 - 08/30/2027

Close Access Date: 09/30/2027

Instructions

1. Click on the Contents tab to begin this activity.  
2. Click Complete GPRA Evaluation to provide valuable activity feedback. Scroll down on all questions as there may be answer options that expand past the size of the window. 
3. Click Claim Certificate of Completion to view/print certificate.  

Need Assistance?

For assistance logging in, accessing activities, claiming credit, or for other questions or concerns, please check the FAQ page, or contact pcssmaud@asam.org.

Accreditation & Credit Designation Statements

Joint Accreditation Statement

In support of improving patient care, the American Society of Addiction Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

National Board for Certified Counselors ACEP 

This activity offers 1 NBCC Contact Hour(s).

The American Society of Addiction Medicine has been approved by NBCC as an Approved Continuing Education Provider, ACEP No. 7062. Programs that do not qualify for NBCC credit are clearly identified. The American Society of Addiction Medicine is solely responsible for all aspects of the programs.

NAADAC, The Association for Addiction Professionals

This course has been approved by the American Society of Addiction Medicine (ASAM) as a NAADAC Approved Education Provider, for 1 CE(s). NAADAC Provider #295, the American Society of Addiction Medicine (ASAM) is responsible for all aspects of its programing.

California Association for Drug/Alcohol Educators (CAADE)

This educational program is approved by CAADE: #CP40 999 1225.

California Association of DUI Treatment Centers (CADTP)

This educational program is approved by CADTP: #205.

California Consortium of Addiction Programs and Professionals (CCAPP)

This educational program is approved by CCAPP: #OS-20-330-0227.

Continuing Education Credits (CEUs)

Upon completion of the activity and online evaluation, all other participants may request a certificate of participation. Participants may submit this certificate of participation to their professional organization/institute as documentation for completing this accredited continuing activity.

Disclosure Information

In accordance with the disclosure policies of ASAM and Joint Accreditation, the effort is made to ensure balance, independence, objectivity, and scientific rigor in all accredited continuing education activities. These policies include identifying and mitigating all relevant financial relationships with ineligible companies for those involved in the creation and dissemination of accredited continuing education.

The following planners have relevant financial relationships:

• Kevin Sevarino, MD, PhD (Advisory Committee/Planner): GlaxoSmithKline, Stockholder

All other planners, faculty, and staff have no relevant financial relationships.

All relevant financial relationships have been identified and mitigated.